The Supreme Court heard oral arguments for Hikma Pharmaceuticals v. Amarin Pharma on Wednesday, a case concerning copyright infringement for generic drug manufacturers.
Stay Connected
Forbes Breaking News on X: https://x.com/ForbesTVNews
Forbes Breaking News on TikTok: https://www.tiktok.com/@forbestvnews
More From Forbes: http://forbes.com